News
-
-
-
COMMUNIQUÉ DE PRESSE
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience
Cambrex announces $120 million investment to expand API manufacturing in the U.S., strengthening drug supply resilience and supporting reshoring initiatives. The investment will increase manufacturing capacity by 40%